Mandate

VINGE ADVISES PANDOX IN RELATION TO ITS LISTING ON NASDAQ STOCKHOLM

June 18, 2015

Vinge advises Pandox Aktiebolag (publ) in relation to its listing on Nasdaq Stockholm. A prospectus was published on 8 June 2015 and the first day of trading on Nasdaq Stockholm was 18 June 2015. The price in the offering was set at SEK 106 per share, corresponding to a market value of all shares issued by Pandox of SEK 15,900 million. The total value of the offering amounts to SEK 6,360 million, assuming that the over-allotment option is exercised in full.

Pandox is a leading owner of hotel properties located in Northern Europe with focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio comprises 104 hotels in the upper medium- and upscale segment with a total of 21,969 hotel rooms across eight countries. The market value of Pandox’s property portfolio amounted to SEK 27 billion as of 31 March 2015.

Vinge’s team consisted mainly of Jesper Schönbeck, Charlotte Levin, Erik Sjöman, David Andersson, Joakim Hagberg, Adam Sandberg and Ludvig Berke. Marie Brommesson assisted in due diligence, including financing and property related matters, and Maria Schultzberg and Tora Hansjons assisted in tax related matters.

Related

Vinge advises Pricer AB in connection with its issuance of senior unsecured bonds and early redemption

Vinge advises Pricer AB (publ) in connection with its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework of SEK 500 million and early redemption of existing bonds.
December 10, 2024

Vinge advises Carasent in connection with the listing on Nasdaq Stockholm

Vinge advises Carasent AB (publ) in connection with the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent AB takes over Carasent ASA, previously listed on Oslo Stock Exchange.
December 09, 2024

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.
December 06, 2024